{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:37:26Z","timestamp":1780360646288,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Science Foundation of China","award":["81930033"],"award-info":[{"award-number":["81930033"]}]},{"name":"Science Foundation of China","award":["81771465"],"award-info":[{"award-number":["81771465"]}]},{"name":"STI2030-Major Projects","award":["2021ZD0200700"],"award-info":[{"award-number":["2021ZD0200700"]}]},{"name":"NSFC Projects of International Cooperation and Exchanges"},{"name":"Clinical Research Center of Shanghai Mental Health Center Key Project","award":["CRC2021ZD01"],"award-info":[{"award-number":["CRC2021ZD01"]}]},{"DOI":"10.13039\/501100012130","name":"Chinese Aeronautical Establishment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019330","name":"Shanghai Clinical Research Center for Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81761128032"],"award-info":[{"award-number":["81761128032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jad.2025.119460","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T05:29:20Z","timestamp":1748150960000},"page":"119460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Strategies for antidepressant medications in the maintenance phase: A systematic review and network Meta-analysis"],"prefix":"10.1016","volume":"387","author":[{"given":"Ziyi","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond W.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jad.2025.119460_bb0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.cpr.2007.02.005","article-title":"Risk for recurrence in depression","volume":"27","author":"Burcusa","year":"2007","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2025.119460_bb0010","series-title":"Individualized Treatment Strategy for Depressive Disorder","first-page":"219","author":"Chen","year":"2019"},{"issue":"5","key":"10.1016\/j.jad.2025.119460_bb0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare","year":"2015","journal-title":"Review. Journal of Psychopharmacology."},{"issue":"3","key":"10.1016\/j.jad.2025.119460_bb0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000530692","article-title":"Discontinuation of antidepressant medications: a significant healthcare problem insufficiently addressed by the NICE guidelines","volume":"92","author":"Cosci","year":"2023","journal-title":"Editorial. Psychotherapy and Psychosomatics."},{"issue":"3","key":"10.1016\/j.jad.2025.119460_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/da.22872","article-title":"Relapse prevention with levomilnacipran ER in adults with major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study","volume":"36","author":"Durgam","year":"2019","journal-title":"Depress. Anxiety"},{"issue":"4","key":"10.1016\/j.jad.2025.119460_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000491524","article-title":"Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review","volume":"87","author":"Fava","year":"2018","journal-title":"Review. Psychotherapy and Psychosomatics."},{"issue":"1","key":"10.1016\/j.jad.2025.119460_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199901000-00002","article-title":"Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression","volume":"14","author":"Feiger","year":"1999","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119460_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2022.10.005","article-title":"Antidepressant discontinuation syndrome: a state-of-the-art clinical review","volume":"66","author":"Fornaro","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2025.119460_bb0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004714-200108000-00009","article-title":"Fluoxetine in the prevention of depressive recurrences: a double-blind study","volume":"21","author":"Gilaberte","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"S","key":"10.1016\/j.jad.2025.119460_bb0050","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.ypmed.2014.07.035","article-title":"Interventions for preventing relapse or recurrence of depression in primary health care settings: a systematic review","volume":"76","author":"Gili","year":"2015","journal-title":"Prev. Med."},{"issue":"8","key":"10.1016\/j.jad.2025.119460_bb0055","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.08m04548","article-title":"Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial","volume":"70","author":"Goodwin","year":"2009","journal-title":"Article. Journal of Clinical Psychiatry."},{"issue":"7","key":"10.1016\/j.jad.2025.119460_bb0060","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.JGP.0000240823.94522.4c","article-title":"Escitalopram prevents relapse in older patients with major depressive disorder","volume":"15","author":"Gorwood","year":"2007","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2025.119460_bb0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/11530230-000000000-00000","article-title":"Defining and measuring functional recovery from depression","volume":"24","author":"Greer","year":"2010","journal-title":"CNS Drugs."},{"issue":"20","key":"10.1016\/j.jad.2025.119460_bb0070","first-page":"355","article-title":"The diagnosis and treatment of unipolar depression. Dtsch Arztebl","volume":"120","author":"H\u00e4rter","year":"2023","journal-title":"International"},{"issue":"20","key":"10.1016\/j.jad.2025.119460_bb0075","first-page":"355","article-title":"Antidepressant withdrawal and rebound phenomena","volume":"116","author":"Henssler","year":"2019","journal-title":"Dtsch. Arztebl. Int."},{"issue":"APR","key":"10.1016\/j.jad.2025.119460_bb0080","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1192\/bjp.178.4.304","article-title":"Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy","volume":"178","author":"Hochstrasser","year":"2001","journal-title":"Br. J. Psychiatry"},{"issue":"JULY","key":"10.1016\/j.jad.2025.119460_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1192\/bjp.181.1.29","article-title":"Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy","volume":"181","author":"Klysner","year":"2002","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2025.119460_bb0090","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archpsyc.59.8.723","article-title":"Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo","volume":"59","author":"Kocsis","year":"2002","journal-title":"Article. Archives of General Psychiatry."},{"issue":"11","key":"10.1016\/j.jad.2025.119460_bb0095","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4088\/JCP.v67n1115","article-title":"Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial","volume":"67","author":"Kornstein","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.119460_bb0100","first-page":"94","article-title":"Common questions about the pharmacologic management of depression in adults","volume":"92","author":"Kovich","year":"2015","journal-title":"Am. Fam. Physician"},{"issue":"9","key":"10.1016\/j.jad.2025.119460_bb0105","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/0706743716659416","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care","volume":"61","author":"Lam","year":"2016","journal-title":"Review. Canadian Journal of Psychiatry."},{"issue":"9","key":"10.1016\/j.jad.2025.119460_bb0110","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/07067437241245384","volume":"69","author":"Lam","year":"2024","journal-title":"Can. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2025.119460_bb0120","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1176\/appi.ajp.161.5.836","article-title":"A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder","volume":"161","author":"L\u00e9pine","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"14","key":"10.1016\/j.jad.2025.119460_bb0125","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMoa2106356","article-title":"Maintenance or discontinuation of antidepressants in primary care","volume":"385","author":"Lewis","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jad.2025.119460_bb0130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpsyc.63.5.521","article-title":"Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Lustman","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10161","key":"10.1016\/j.jad.2025.119460_bb0135","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jad.2025.119460_bb0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00004850-199300830-00009","article-title":"Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression","volume":"8","author":"Montgomery","year":"1993","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2025.119460_bb0145","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4088\/JCP.v65n0307","article-title":"Venlafaxine versus placebo in the preventive treatment of recurrent major depression","volume":"65","author":"Montgomery","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2025.119460_bb0150","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1586\/14737175.6.7.1049","article-title":"Combination pharmacotherapy in unipolar depression","volume":"6","author":"Ng","year":"2006","journal-title":"Expert. Rev. Neurother."},{"issue":"8","key":"10.1016\/j.jad.2025.119460_bb0155","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S2215-0366(22)00158-4","article-title":"Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis","volume":"9","author":"Ostuzzi","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2025.119460_bb0160","series-title":"Comparison in clinical efficacy about continuing, reducing, switching, or stopping antidepressant medications in patients with major depressive disorders who are clinically stable: a systematic review and network meta-analysis","author":"Pan","year":"2023"},{"issue":"APR.","key":"10.1016\/j.jad.2025.119460_bb0165","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1192\/bjp.188.4.346","article-title":"Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study","volume":"188","author":"Perahia","year":"2006","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.119460_bb0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4088\/JCP.v65n0107","article-title":"Escitalopram continuation treatment prevents relapse of depressive episodes","volume":"65","author":"Rapaport","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2025.119460_bb0175","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cpr.2011.07.004","article-title":"Prevalence and clinical course of depression: a review","volume":"31","author":"Richards","year":"2011","journal-title":"Review. Clinical Psychology Review."},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2025.119460_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004850-199503001-00006","article-title":"Citalopram in doses of 20-60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study","volume":"10","author":"Robert","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.jad.2025.119460_bb0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5694\/mja2.50522","article-title":"Antidepressant-induced sexual dysfunction","volume":"212","author":"Rothmore","year":"2020","journal-title":"Med. J. Aust."},{"issue":"3","key":"10.1016\/j.jad.2025.119460_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004850-200015030-00002","article-title":"Milnacipran efficacy in the prevention of recurrent depression: a 12-month placebo-controlled study","volume":"15","author":"Rouillon","year":"2000","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"10312","key":"10.1016\/j.jad.2025.119460_bb0195","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Santomauro","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jad.2025.119460_bb0200","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4088\/JCP.v61n1107","article-title":"The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder","volume":"61","author":"Schmidt","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.119460_bb0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jpsychires.2003.10.004","article-title":"Extended-release venlafaxine in relapse prevention for patients with major depressive disorder","volume":"38","author":"Simon","year":"2004","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jad.2025.119460_bb0210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41380-021-01285-w","article-title":"The relationship between dose and serotonin transporter occupancy of antidepressants\u2014a systematic review","volume":"27","author":"S\u00f8rensen","year":"2022","journal-title":"Review. Molecular Psychiatry."},{"issue":"2","key":"10.1016\/j.jad.2025.119460_bb0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00004850-199803000-00001","article-title":"Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study","volume":"13","author":"Terra","year":"1998","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.jad.2025.119460_bb0220","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4088\/JCP.v62n1006","article-title":"Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients","volume":"62","author":"Thase","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.119460_bb0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2022.02.002","article-title":"Vortioxetine 5, 10, and 20 mg significantly reduces the risk of relapse compared with placebo in patients with remitted major depressive disorder: the RESET study","volume":"303","author":"Thase","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119460_bb0230","series-title":"Standardized treatment strategy for depressive disorder","first-page":"193","author":"Wang","year":"2019"},{"issue":"JUNE","key":"10.1016\/j.jad.2025.119460_bb0235","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1192\/bjp.182.6.492","article-title":"Older community residents with depression: long-term treatment with sertraline: randomised, double-blind, placebo-controlled study","volume":"182","author":"Wilson","year":"2003","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119460_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109755","article-title":"Causes of drug discontinuation in patients with major depressive disorder in China","volume":"96","author":"Zhu","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.119460_bb0245","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.2147\/NDT.S317770","article-title":"Comparison of residual depressive symptoms, functioning, and quality of life between patients with recurrent depression and first episode depression after acute treatment in China","volume":"17","author":"Zu","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.jad.2025.119460_bb0250","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3949\/ccjm.89a.21020","article-title":"Discontinuing antidepressants: pearls and pitfalls","volume":"89","author":"Zwiebel","year":"2022","journal-title":"Cleve. Clin. J. Med."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725009024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725009024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T07:58:34Z","timestamp":1749887914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725009024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":49,"alternative-id":["S0165032725009024"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.119460","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for antidepressant medications in the maintenance phase: A systematic review and network Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.119460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119460"}}